Internal Server Error

About UTEC

UTEC is a venture capital firm founded in 2004. It is primarily based out of Tokyo, Japan. As of Jul 2026, UTEC is an active investor, having invested in 134 companies, with 8 new investments in the last 12 months. It primarily invests in Series A round in Japan based startups. Its investments are spread across a wide range of sectors from High Tech to Life Sciences and Enterprise Applications. Most recently it participated in the $***** Series B round of KUZEN Overall, UTEC portfolio has seen 20 IPOs and 11 acquisitions including key companies like 908 Devices, Autonomous Control Systems Laboratory and MediciNova. A lot of funds co-invest with UTEC, with names like SMBC Venture Capital sharing a substantial percentage of its portfolio. UTEC has team of 30 people including 10 partners.
Key Metrics
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 2 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months

UTEC's List of Top Investments

UTEC has a portfolio of 134 companies. Their most notable investments are in Startbahn and X Mile.Their portfolio spans across Japan, United States, Singapore and 4 more locations. They have invested in High Tech, Life Sciences, Enterprise Applications and 28 other sectors, across stages such as Series A, Seed  and 2 more. Here is the list of top investments by UTEC:
Manufacturer of detection device for chemical analysis using mass spectrometry. It offers battery-operated, handheld, chemical detection tools, and personal analyzers for biologists and chemists. It develops its products using mass spectrometry technology that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes.

Key facts about 908 Devices

Autonomous driving platforms and intelligent vehicle systems. It focuses on creating scalable technologies for self-driving cars using open-source software and hardware integration. The company supports mobility and logistics applications by offering platforms that enable automated vehicle control and deployment.

Key facts about Tier4 Robotics

Developer of electric vertical takeoff and landing aircraft for urban air mobility. This company designs and manufactures electric air taxis intended to alleviate traffic congestion. The aircraft are designed for intra-city travel, offering a faster, quieter, and more sustainable alternative to traditional transportation methods. The focus is on creating a safe and efficient aerial mobility solution for both passengers and cargo.

Key facts about E-plane

  • Founded Year: 2019
  • Location: Chennai (India)
  • Annual Revenue: 0 - ₹10 Cr as on Mar 31, 2025
  • Valuation: $*****
  • Stage: Series B
  • Total Funding till date: $21.5M
  • Employee Count: 135 as on Aug 31, 2025
  • Investors: 3one4 Capital, LetsVenture and 77 Others
  • Latest Funding Round: Series B, Oct 29, 2024, $*****
  • Highlight: Editors' Pick
Provider of AI-enabled platform for remote cardiac diagnosis and management. The platform offers solutions for clinics, hospitals, diagnostics centers, and public health organizations. It facilitates timely and accurate electrocardiogram interpretation, workflow digitization, and integration with existing laboratory information systems. The platform aims to improve access to cardiac care and reduce mortality rates.

Key facts about Tricog

  • Founded Year: 2014
  • Location: Bengaluru (India)
  • Annual Revenue: ₹50 - ₹100 Cr as on Mar 31, 2025
  • Valuation: $*****
  • Stage: Series B
  • Total Funding till date: $30M
  • Employee Count: 362 as on Jun 30, 2026
  • Investors: Blume Venture, Aflac Ventures and 28 Others
  • Latest Funding Round: Series B, Apr 20, 2023, $*****
  • Highlight: Editors' Pick
immunoSCAPE offers specialized services for biomarker and target identification through its unique high-dimensional immune profiling platform. Founded as a spin-off from the lab of Dr Evan Newell at Singapore Immunology Network, A*STAR, the company uses its expertise in immunology and mass cytometry to measure alterations of immune cells and T-cell specificity in specific and helps in optimizing the early phase R&D pipeline for oncology and infectious diseases.Their proprietary technology leverages the power of mass cytometry (Cytometry by Time of Flight), T-Cell antigen discovery and cell profiling techniques and related data analysis tools. Their services for immunotherapy development include surrogate marker ID, disease status and progression determination and prediction, discovery of novel targets and biomarkers, and efficacy assessment in preclinical and clinical stages.

Key facts about ImmunoSCAPE

  • Founded Year: 2016
  • Location: Singapore (Singapore)
  • Stage: Series B
  • Total Funding till date: $39M
  • Employee Count: 21 as on Jun 30, 2026
  • Investors: EDBI, Amgen and 16 Others
  • Latest Funding Round: Series B, Sep 20, 2022, $*****
  • Highlight: Editors' Pick

UTEC's Investments by Stage

UTEC has made 48 investments in Series A stage with an average round size of $7.53M, 27 investments in Seed stage with an average round size of $8.49M, 13 investments in Series B stage with an average round size of $24.8M and 4 investments in Series C stage with an average round size of $20.2M.
Here are UTEC's investments by stage:
Stage of entry
No. of Investments
Series A
48
Seed
27
Series B
13
Series C
4
Breakdown of UTEC's investments by stage of entrySeries A (48)Seed (27)
Note: We have considered here, only first round of investments

UTEC's Investments by Sector

UTEC has a diverse portfolio, with companies operating in the High Tech, Enterprise Applications, Life Sciences, Consumer and Industrial Goods and Manufacturing. Notably, it has invested in 102 Tech companies, 96 Enterprise (B2B) companies, 55 Software companies and at least 27 companies focusing on Tech hardware.
Here are UTEC's investments by sector:
Sector
No. of Investments
High Tech
37
Enterprise Applications
28
Life Sciences
23
Consumer
9
Industrial Goods and Manufacturing
8
Others
95
Breakdown of UTEC's investments by sectorsHigh Tech (37)Enterprise Applic... (28)
Note: We have considered here, only first round of investments

UTEC's Investments by Geography

UTEC has made most investments in Japan (63), followed by United States where it has made 16 investments.
Here are UTEC's investments by geography:
Country
No. of Investments
Japan
63
United States
16
India
5
Singapore
4
United Kingdom
3
Others
2
Breakdown of UTEC's investments by countriesJapan (63)United States (16)
Note: We have considered here, only first round of investments

UTEC's recent investments

UTEC has made 9 investments in 2026 so far. KUZEN and ALGO ARTIS are the latest among them.
Here are the most recent investments by UTEC:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Jul 07, 2026
Japan
Series B
6970
Jun 09, 2026
Japan
Series B
8646
Jun 01, 2026
Japan
Seed
7510
 
Jun 01, 2026
Japan
Series B
3585
May 18, 2026
United States
Seed
6853

IPOs and Publicly Listed companies in UTEC's Portfolio

20 of UTEC's portfolio companies have become public. ZenmuTech got listed on the Tokyo Stock Exchange (TYO), in Mar 2025 at marketcap of $11.2M and ELEMENTS got listed on the Tokyo Stock Exchange (TSE) at marketcap of $24M.
Here are UTEC's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Mar 27, 2025
Apr 14, 2016
Seed
5526
Dec 27, 2022
-
-
3941
Dec 01, 2022
Jan 23, 2013
Series A
6456
Jun 24, 2022
-
-
7817
Dec 29, 2021
-
-
7201

Acquired companies in UTEC's Portfolio

11 companies from UTEC's portfolio have been acquired. The most recent acquisition was Aidemy Japan in Aug 2025 by Accenture for $*****.
Here are UTEC's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Aug 14, 2025
Nov 01, 2017
Seed
4510
Apr 02, 2025
Apr 16, 2020
Series A
1916
Jan 04, 2023
Apr 08, 2019
Series A
3235
May 31, 2022
Nov 21, 2014
Series A
7991
Nov 02, 2021
Jan 28, 2021
Seed
5655

Team profile of UTEC

UTEC has a team of 30 members including 10 Partners, 3 Venture Partners and 6 Principals located in Japan, United States and 2 more locations. UTEC's team sits on the board of 2 companies.
Here is a list of top team members in UTEC:
Name
Designation
Location
Board Memberships
Contact Details
Partner
Tokyo
-
-
Partner
Tokyo
-
Partner
Detroit
-
Partner
-
-
-
Partner
Tokyo
-
Partner
Tokyo
Partner
Japan
-
Partner
Johns Island
-
-
Partner
Schertz
-
Partner
Kazakhstan
-
-
Venture Partner
Tokyo
-
-

Co-investors of UTEC

Over the past 22 years, 592 investors have co-invested in UTEC's portfolio companies. This includes funds and angels.

  • Invested before UTECBlume Venture, Ukri and 151 others have invested in rounds before UTEC. There are 3 companies where Blume Venture has invested before UTEC and 2 companies where Ukri has invested before UTEC.
  • Top Co-investors of UTEC181 investors entered a company along with UTEC. These include investors like SMBC Venture Capital (5 companies).
  • Invested after UTECA total of 258 investors have invested in UTEC's portfolio after their investments. Top Investors include SBI Investment (4 companies), Daiwa Corporate Investment (4 companies) and Japan Post Capital (3 companies).

Recent News related to UTEC

View all news related to UTEC

FAQs about UTEC

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford